TCF7L2 enhances anoikis resistance in gastric cancer,14 whereas cell migration‐inducing protein promotes anoikis resistance in prostate tumors by activating the miR‐1248/TM9SF4 axis.15 The gene discussed is TCF7L2; the disease is gastric cancer.